Myofascial pain and fibromyalgia: where the evidence differs · Review · 2022
What do studies show about shockwave for myofascial pain and fibromyalgia?
This review mapped 19 studies of shockwave for myofascial (muscle knot) pain. Shockwave generally did better than sham; against active treatments such as dry needling or injections, results were mixed. No fibromyalgia trials qualified, so the fibromyalgia plan the authors suggest has not been tested.
- studies on myofascial pain
- 19
- of them randomized trials
- 15
- fibromyalgia trials that qualified
- 0
Good to know: A map of earlier studies, not a combined result: 12 used radial and 7 focused shockwave.
Paoletta M, Moretti A, Liguori S, et al. Medicina (Kaunas, Lithuania), 2022 · Read the paper ↗
How this study worked
Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.
What the trials used
- Protocol map
- Radial protocols generally used 1,000–4,500 pulses and focused protocols 1,000–3,000 pulses at 0.056–0.25 mJ/mm². Three sessions one week apart were common, but schedules varied. Tables contain inconsistent units and modality descriptions, so these ranges are a map of reporting rather than a validated prescription.
- Untested fibromyalgia proposal
- Authors propose 3,000 focused or 4,500 radial pulses divided among four or five painful regions, adjusted to tolerance; not a validated protocol.
Who took part
People with myofascial pain in the trapezius, lower back, thigh or calf muscles, across 19 studies; none of the studies was in fibromyalgia.
Side effects
The review gives no overall side-effect figures; one comparison mentions soreness after dry needling.
All the numbers and the full appraisal
Every reported result
What the full paper reports.
All 19 eligible studies concerned myofascial pain: 12 radial and seven focused; 15 randomized trials and four observational reports. No eligible fibromyalgia trial was identified. Sites included trapezius, quadratus lumborum, quadriceps and gastrocsoleus, with a broad mixed myofascial/articular retrospective cohort.
Mixed active-comparator results1 reported outcome
Mixed active-comparator results
Mixed active-comparator results Narrative finding
Sham comparisons generally favored ESWT, while active-treatment comparisons were mixed. Dry-needling and some ultrasound comparisons found no clear superiority. Jeon found no pain/mobility advantage over injection plus TENS; Hong reported a pain advantage without disability differences. Eftekharsadat favored corticosteroid injection at two weeks and radial therapy at one month. There is no eligible trial evidence for fibromyalgia.
Analysis details and source
Qualitative finding; no invented effect estimate.
No eligible fibromyalgia evidence1 reported outcome
No eligible fibromyalgia evidence
No eligible fibromyalgia evidence Narrative finding
No eligible FM study; proposed 3,000 focused or 4,500 radial pulses distributed across painful regions is not a tested treatment result.
Analysis details and source
Qualitative finding; no invented effect estimate.
Pain and disability need separate interpretation1 reported outcome
Pain and disability need separate interpretation
Pain and disability need separate interpretation Narrative finding
Hong: pain favored focused therapy, disability indices did not; Jeon: no significant pain or neck mobility difference from injection plus TENS.
Analysis details and source
Qualitative finding; no invented effect estimate.
How treatment was delivered
Radial protocols generally used 1,000–4,500 pulses and focused protocols 1,000–3,000 pulses at 0.056–0.25 mJ/mm². Three sessions one week apart were common, but schedules varied. Tables contain inconsistent units and modality descriptions, so these ranges are a map of reporting rather than a validated prescription.
Authors propose 3,000 focused or 4,500 radial pulses divided among four or five painful regions, adjusted to tolerance; not a validated protocol.
No pooled adverse-event frequency is provided. One dry-needling comparison mentions soreness after dry needling, which is not a complete comparative safety analysis. Authors declared no funding or conflicts.
Single-database, English-only searching and qualitative synthesis can miss studies and cannot quantify comparative benefit. Study design, anatomy, controls and dosing differ markedly. Some table units and modality labels conflict with narrative; primary papers should govern protocol decisions. The proposed fibromyalgia protocol was not tested.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Single-database, English-only searching and qualitative synthesis can miss studies and cannot quantify comparative benefit. Study design, anatomy, controls and dosing differ markedly. Some table units and modality labels conflict with narrative; primary papers should govern protocol decisions. The proposed fibromyalgia protocol was not tested.
Source-linked critical reading
PRISMA-ScR scoping review of English-language human interventional and observational studies in PubMed through December 2021. Nineteen studies were included from 76 search records; no pooled effect or formal certainty assessment is supplied.
Technical source record
Full local PDF read; All 13 PDF pages; Methods; Results; Tables 1–4; Figures 1–3 and captions; Discussion and proposed untested FM protocol; Conclusions; disclosures; references
Shockwaves may help some people with regional myofascial pain, but the best regimen and superiority to other active care remain uncertain. This review found no eligible fibromyalgia trial, so its suggested protocol is an untested research proposal.
What clinical evidence supports radial or focused ESWT for myofascial pain syndrome and fibromyalgia?
PRISMA-ScR scoping review of English-language human interventional and observational studies in PubMed through December 2021. Nineteen studies were included from 76 search records; no pooled effect or formal certainty assessment is supplied.
All 19 eligible studies concerned myofascial pain: 12 radial and seven focused; 15 randomized trials and four observational reports. No eligible fibromyalgia trial was identified. Sites included trapezius, quadratus lumborum, quadriceps and gastrocsoleus, with a broad mixed myofascial/articular retrospective cohort.
Radial protocols generally used 1,000–4,500 pulses and focused protocols 1,000–3,000 pulses at 0.056–0.25 mJ/mm². Three sessions one week apart were common, but schedules varied. Tables contain inconsistent units and modality descriptions, so these ranges are a map of reporting rather than a validated prescription.
Comparators included dry needling, laser, ultrasound, exercise, sham/very-low-energy treatment, trigger-point injections, kinesiology taping and topical diclofenac. The review does not provide a direct pooled radial-versus-focused comparison.
Tables 3–4 summarize pain, pressure pain threshold, neck/back disability, range of motion, quality of life and some sleep/depression measures at differing times. Most entries provide directions or significance, not group means, effect sizes or confidence intervals.
Sham comparisons generally favored ESWT, while active-treatment comparisons were mixed. Dry-needling and some ultrasound comparisons found no clear superiority. Jeon found no pain/mobility advantage over injection plus TENS; Hong reported a pain advantage without disability differences. Eftekharsadat favored corticosteroid injection at two weeks and radial therapy at one month. There is no eligible trial evidence for fibromyalgia.
No pooled adverse-event frequency is provided. One dry-needling comparison mentions soreness after dry needling, which is not a complete comparative safety analysis. Authors declared no funding or conflicts.
Single-database, English-only searching and qualitative synthesis can miss studies and cannot quantify comparative benefit. Study design, anatomy, controls and dosing differ markedly. Some table units and modality labels conflict with narrative; primary papers should govern protocol decisions. The proposed fibromyalgia protocol was not tested.
The review supports research and clinical discussion for regional myofascial pain, but a trigger-point response cannot be generalized to widespread fibromyalgia. Mechanism diagrams are hypotheses, not measured outcomes in these patients.
Test clearly specified regimens against credible sham and active care, distinguish radial from focused devices, report harms and meaningful functional change, and study fibromyalgia directly before recommending the proposed schedule.
Read the original article.
Efficacy and Effectiveness of Extracorporeal Shockwave Therapy in Patients with Myofascial Pain or Fibromyalgia: A Scoping Review.
Paoletta M, Moretti A, Liguori S, Toro G, Gimigliano F, Iolascon G. · Medicina (Kaunas, Lithuania) · 2022
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →